Immatics Teams With MD Anderson On Novel Immuno-Oncology Targets
This article was originally published in The Pink Sheet Daily
Executive Summary
The partners will work together to develop three types of adoptive cellular therapies for cancer, with a first candidate slated to begin clinical development in 2016.